Orally Disintegrating Tablet Excipient Market Trends and Forecast
The future of the global orally disintegrating tablet excipient market looks promising with opportunities in the anti-psychotics drug and anti-epileptics drug markets. The global orally disintegrating tablet excipient market is expected to grow with a CAGR of 5.6% from 2025 to 2031. The major drivers for this market are the increasing demand for patient-friendly drug formulations, the rising prevalence of neurological disorders globally, and the growing adoption of fast-dissolving tablet technology.
• Lucintel forecasts that, within the type category, binder is expected to witness the highest growth over the forecast period.
• Within the application category, anti-epileptics drug is expected to witness higher growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.
Emerging Trends in the Orally Disintegrating Tablet Excipient Market
The market for orally disintegrating tablet excipient is evolving with innovations in formulation technology, regulatory advancements, and increasing consumer demand for fast-dissolving drug delivery systems.
• Rising Demand for Natural Excipients: Consumers and regulators are favoring natural and plant-based excipients, leading to increased research and commercialization of sustainable alternatives.
• Advancements in Co-processed Excipients: New excipient combinations are improving drug stability, dissolution rates, and overall tablet performance, making formulations more effective.
• Expansion of Pediatric and Geriatric Applications: Orally disintegrating tablets are increasingly used in pediatric and geriatric medicine, driving demand for specialized excipients with enhanced safety and taste-masking properties.
• Regulatory Focus on Excipient Quality and Safety: Governments are tightening regulations on excipient manufacturing, ensuring better quality control and compliance in pharmaceutical applications.
• Growth in Biopharmaceutical Applications: Excipient manufacturers are developing advanced materials for biologic drugs, enhancing drug stability and patient adherence.
These trends are shaping the market by improving excipient quality, expanding applications, and increasing compliance with regulatory standards.
Recent Development in the Orally Disintegrating Tablet Excipient Market
The orally disintegrating tablet excipient market is witnessing significant advancements in excipient technology, regulatory frameworks, and manufacturing processes, contributing to improved drug formulations.
• Innovation in Sugar-based Excipients: New sugar-based excipients are being developed to enhance the taste and disintegration of orally disintegrating tablets, improving patient compliance.
• Increased Investment in Nanotechnology: Pharmaceutical firms are using nanotechnology to optimize excipient properties, resulting in better drug absorption and faster dissolution rates.
• Expansion of GMP-certified Manufacturing Facilities: Companies are upgrading facilities to meet good manufacturing practice (GMP) standards, ensuring high-quality excipient production.
• Regulatory Approvals for New Excipient Combinations: Authorities are approving novel excipient blends that improve tablet performance, stability, and dissolution characteristics.
• Adoption of Sustainable and Eco-friendly Excipients: Manufacturers are shifting toward biodegradable and non-toxic excipients to meet growing sustainability demands.
These developments are driving market expansion by enhancing drug formulation quality, improving compliance with global standards, and meeting patient preferences.
Strategic Growth Opportunities in the Orally Disintegrating Tablet Excipient Market
Growth opportunities in the orally disintegrating tablet excipient market are driven by advancements in formulation science, increasing demand for fast-dissolving medications, and regulatory changes promoting excipient innovation.
• Development of Multifunctional Excipients: Innovations in excipients that combine multiple functional properties are reducing the need for additional formulation ingredients, streamlining drug development.
• Expansion in Personalized Medicine Applications: The increasing focus on precision medicine is leading to demand for customized excipient solutions that enhance drug efficacy for specific patient populations.
• Integration of Artificial Intelligence in Excipient Research: AI is being used to optimize excipient selection and formulation processes, improving efficiency and reducing development time.
• Growth in Pediatric and Geriatric Healthcare Segments: The rising need for patient-friendly drug delivery solutions is creating demand for specialized excipients tailored to these populations.
• Increased Collaboration Between Pharmaceutical and Excipient Companies: Strategic partnerships are driving innovation in excipient functionality, stability, and compatibility with active pharmaceutical ingredients.
These opportunities are transforming the market by enhancing formulation science, improving drug performance, and expanding applications in personalized medicine and targeted drug delivery.
Orally Disintegrating Tablet Excipient Market Driver and Challenges
The market is influenced by various drivers, such as technological advancements, regulatory support, and increasing patient demand. However, challenges related to cost, quality control, and regulatory compliance persist.
The factors responsible for driving the orally disintegrating tablet excipient market include:
1. Rising Demand for Patient-friendly Drug Delivery Systems: The increasing preference for orally disintegrating tablets among pediatric and geriatric populations is driving excipient market growth.
2. Technological Advancements in Excipient Development: Innovations in co-processed excipients and nanotechnology are enhancing drug stability, dissolution rates, and overall tablet effectiveness.
3. Stringent Regulatory Frameworks Ensuring Quality Compliance: Regulatory bodies are emphasizing excipient safety, pushing manufacturers to improve production quality and adherence to pharmaceutical standards.
4. Expansion of the Generic Drug Market: Growth in generic drug production is increasing demand for cost-effective excipients that ensure bioequivalence and stability.
5. Growing Focus on Sustainable and Natural Excipients: Consumer and regulatory pressure to use biodegradable and plant-based excipients is driving research in eco-friendly alternatives.
Challenges in the orally disintegrating tablet excipient market are:
1. High Cost of Advanced Excipient Technologies: The development and adoption of innovative excipient formulations require significant investment, limiting access for smaller pharmaceutical firms.
2. Complex Regulatory Approval Processes: Varying excipient regulations across different countries create challenges for manufacturers seeking global market entry.
3. Supply Chain Disruptions and Raw Material Shortages: Fluctuations in raw material availability impact excipient production and pricing, affecting market stability.
The market is poised for growth due to technological innovations and increasing demand for patient-friendly drug formulations. However, addressing cost, regulatory, and supply chain challenges will be crucial for sustained market expansion.
List of Orally Disintegrating Tablet Excipient Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies orally disintegrating tablet excipient companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the orally disintegrating tablet excipient companies profiled in this report include-
• BASF
• JRS Pharma
• Roquette
• ABF Ingredients
• DFE Pharma
• Evonik
• Merck
• Ashland
• Meggle Pharma
• Shin-Etsu
Orally Disintegrating Tablet Excipient Market by Segment
The study includes a forecast for the global orally disintegrating tablet excipient market by type, application, and region.
Orally Disintegrating Tablet Excipient Market by Type [Value from 2019 to 2031]:
• Binders
• Glidants
• Diluents
• Disintegrants
• Others
Orally Disintegrating Tablet Excipient Market by Application [Value from 2019 to 2031]:
• Anti-Psychotics Drug
• Anti-Epileptics Drug
• Others
Orally Disintegrating Tablet Excipient Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Orally Disintegrating Tablet Excipient Market
The orally disintegrating tablet excipient market is experiencing significant growth due to rising demand for patient-friendly drug formulations. Advancements in excipient technology, regulatory approvals, and expanding production capabilities in key regions are driving market expansion.
• United States: The United States is leading research in novel excipient formulations to enhance drug stability and bioavailability. The FDA is approving new excipient combinations, and pharmaceutical firms are investing in advanced manufacturing processes.
• China: China is expanding its excipient production capabilities to support the growing pharmaceutical industry. Government initiatives are promoting innovation, and local manufacturers are entering global supply chains.
• Germany: Germany is focusing on improving excipient quality through regulatory advancements. The country is also witnessing increased collaboration between pharmaceutical companies and excipient manufacturers to enhance tablet performance.
• India: India is emerging as a major supplier of excipients due to cost-effective production and increasing exports. However, challenges such as quality standardization and regulatory compliance need to be addressed.
• Japan: Japan is advancing research in natural and synthetic excipients for orally disintegrating tablets. The country is also implementing stricter regulations to ensure high-quality formulations.
Features of the Global Orally Disintegrating Tablet Excipient Market
Market Size Estimates: Orally disintegrating tablet excipient market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Orally disintegrating tablet excipient market size by type, application, and region in terms of value ($B).
Regional Analysis: Orally disintegrating tablet excipient market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the orally disintegrating tablet excipient market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the orally disintegrating tablet excipient market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for orally disintegrating tablet excipient market?
Answer: The global orally disintegrating tablet excipient market is expected to grow with a CAGR of 5.6% from 2025 to 2031.
Q2. What are the major drivers influencing the growth of the orally disintegrating tablet excipient market?
Answer: The major drivers for this market are the increasing demand for patient-friendly drug formulations, the rising prevalence of neurological disorders globally, and the growing adoption of fast-dissolving tablet technology.
Q3. What are the major segments for orally disintegrating tablet excipient market?
Answer: The future of the orally disintegrating tablet excipient market looks promising with opportunities in the anti-psychotics drug and anti-epileptics drug markets.
Q4. Who are the key orally disintegrating tablet excipient market companies?
Answer: Some of the key orally disintegrating tablet excipient companies are as follows:
• BASF
• JRS Pharma
• Roquette
• ABF Ingredients
• DFE Pharma
• Evonik
• Merck
• Ashland
• Meggle Pharma
• Shin-Etsu
Q5. Which orally disintegrating tablet excipient market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, binder is expected to witness the highest growth over the forecast period.
Q6. In orally disintegrating tablet excipient market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, North America is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the orally disintegrating tablet excipient market by type (binders, glidants, diluents, disintegrants, and others), application (anti-psychotics drug, anti-epileptics drug, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Orally Disintegrating Tablet Excipient Market, Orally Disintegrating Tablet Excipient Market Size, Orally Disintegrating Tablet Excipient Market Growth, Orally Disintegrating Tablet Excipient Market Analysis, Orally Disintegrating Tablet Excipient Market Report, Orally Disintegrating Tablet Excipient Market Share, Orally Disintegrating Tablet Excipient Market Trends, Orally Disintegrating Tablet Excipient Market Forecast, Orally Disintegrating Tablet Excipient Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.